DuPont vs CVS
Which is stronger right now? The dated snapshot below answers it with quality, valuation ceiling, risk, and timing — side by side, then the full decision brief.
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Key facts — quick answer
- DD = DuPont (US) · CVS = CVS (US).
- Snapshot 2026-08-29: DD $138.80 · signal LONG · ret +57.6% ‖ CVS $92.92 · signal LONG · ret +40.0%.
- The one with the wider gap between price and its valuation ceiling — at equal quality — usually wins the slot.
Snapshot comparison (2026-08-29)
| DD | CVS | |
|---|---|---|
| Company | DuPont | CVS |
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Materials | Healthcare |
| Price | $138.80 | $92.92 |
| Signal | LONG · +57.6% | LONG · +40.0% |
| Total return | +57.6% | +40.0% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
See the full decision brief
Deeper comparison — DuPont (DD) vs CVS (CVS)
Beyond the snapshot above, the real comparison comes from running the same workflow on both companies: score quality, set the valuation ceiling, and write the break conditions for each. The framework stays identical; only the data changes.
| Dimension | DD | CVS |
|---|---|---|
| Market | 🇺🇸 US | 🇺🇸 US |
| Sector | Materials | Healthcare |
| STM signal | LONG | LONG |
| uPnL | +57.6% | +40.0% |
| Total return | +57.6% | +40.0% |
Use this table as a starting point, not an answer. The decision comes from running the full workflow on both companies — DD brief · CVS brief — and comparing the outputs side by side.
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google.
Cite this page
Balance Labs Research Desk. "DuPont vs CVS" https://balancelabs.app/stocks/compare/dd-vs-cvs. Data snapshot: . CC BY 4.0 with attribution.
Ask anything about DD
Same AI engine as this decision brief — grounded in live tool reports.
30 free credits monthly · no card required · research support, not advice
← All guides · Home · Data snapshot 2026-08-29 · Not investment advice.